Following the Money in Medical Devices
Executive Summary
Venture capitalists might cry poor, but, in fact, many leading firms have raised new funds over the past year, pooling more than $1.5 billion for medical device investments. The only question facing entrepreneurs and executives is: are they buying what you’re selling?
You may also be interested in...
Ethicon Buys Acclarent: Can This Exit Open Up ENT?
Traditionally, the ENT space has been a bit of a technology backwater in terms of device innovation. Indeed, it has been more than a decade since the last major ENT deal, which made Medtronic the sole major strategic player in the ENT space. That dynamic has now changed with J&J/Ethicon's acquisition of Acclarent. Now the question is whether this deal will help open up the ENT space to more M&A activity?
Essex Woodlands Partners With Lemaitre to Start White Pine
Dan Lemaitre, who steered CoreValve into a record breaking acquisition by Medtronic, has joined with venture capitalist Guido Neels to form a new device company, White Pine Medical Inc. Neels' firm Essex Woodlands Health Ventures is backing Lemaitre with $50 million.
Ethicon Buys Acclarent: Can This Exit Open Up ENT?
Traditionally, the ENT space has been a bit of a technology backwater in terms of device innovation. Indeed, it has been more than a decade since the last major ENT deal, which made Medtronic the sole major strategic player in the ENT space. That dynamic has now changed with J&J/Ethicon's acquisition of Acclarent. Now the question is whether this deal will help open up the ENT space to more M&A activity?